{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:23:34Z","timestamp":1794349414112,"version":"4.9.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303164"],"award-info":[{"award-number":["82303164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473269"],"award-info":[{"award-number":["82473269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["K2023069"],"award-info":[{"award-number":["K2023069"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.isci.2026.116082","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:35:48Z","timestamp":1790282148000},"page":"116082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["AIM2 in tregs restrains anti-PD-1 efficacy by reinforcing immune suppression in MC38 colorectal cancer"],"prefix":"10.1016","volume":"29","author":[{"given":"Nuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6163-7414","authenticated-orcid":false,"given":"Xiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116082_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejca.2022.09.031","article-title":"Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis","volume":"177","author":"Viscardi","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2026.116082_bib2","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1158\/1078-0432.CCR-22-2241","article-title":"Facts and Hopes in Using Omics to Advance Combined Immunotherapy Strategies","volume":"30","author":"Augustin","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116082_bib3","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1200\/JCO.21.02885","article-title":"Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score \u2265 1% in the KEYNOTE-042 Study","volume":"41","author":"de Castro","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116082_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/d41573-020-00202-0","article-title":"Addressing cancer's grand challenges","volume":"19","author":"Mullard","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.116082_bib5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","article-title":"Therapeutic targeting of regulatory T cells in cancer","volume":"8","author":"Shan","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.isci.2026.116082_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.116082_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1729299","article-title":"PD-L1 is overexpressed on breast cancer stem cells through notch3\/mTOR axis","volume":"9","author":"Mansour","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.isci.2026.116082_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13287-022-02829-9","article-title":"Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy","volume":"13","author":"Dianat-Moghadam","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.isci.2026.116082_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180893","article-title":"Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice","volume":"135","author":"Chen","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.116082_bib10","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.immuni.2025.03.021","article-title":"Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies","volume":"58","author":"Galvez-Cancino","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116082_bib11","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s43018-020-00133-0","article-title":"CD25-T(reg)-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity","volume":"1","author":"Solomon","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.isci.2026.116082_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s43018-023-00547-6","article-title":"CD103(+) regulatory T cells underlie resistance to radio-immunotherapy and impair CD8(+) T cell activation in glioblastoma","volume":"4","author":"van Hooren","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.isci.2026.116082_bib13","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.immuni.2024.07.010","article-title":"Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity","volume":"57","author":"Ichiyama","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116082_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41467-023-44391-9","article-title":"FOXP3(+) regulatory T cell perturbation mediated by the IFN\u03b3-STAT1-IFITM3 feedback loop is essential for anti-tumor immunity","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116082_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54874-y","article-title":"Regulatory T cells crosstalk with tumor cells and endothelium through lymphotoxin signaling","volume":"15","author":"Piao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116082_bib16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41467-025-56002-w","article-title":"Increased SOAT2 expression in aged regulatory T cells is associated with altered cholesterol metabolism and reduced anti-tumor immunity","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116082_bib17","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1016\/j.ymthe.2024.09.010","article-title":"A CD25\u00d7TIGIT bispecific antibody induces anti-tumor activity through selective intratumoral Treg cell depletion","volume":"32","author":"Wei","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2026.116082_bib18","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41423-023-01107-9","article-title":"Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis","volume":"20","author":"Oh","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2026.116082_bib19","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","article-title":"A 360\u00b0 view of the inflammasome: Mechanisms of activation, cell death, and diseases","volume":"186","author":"Barnett","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116082_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1535-7163.MCT-05-0310","article-title":"AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model","volume":"5","author":"Chen","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.isci.2026.116082_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature07710","article-title":"AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA","volume":"458","author":"Fernandes-Alnemri","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116082_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni.1702","article-title":"An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome","volume":"10","author":"B\u00fcrckst\u00fcmmer","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.116082_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100869","article-title":"Immunobiology and structural biology of AIM2 inflammasome","volume":"76","author":"Wang","year":"2020","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.isci.2026.116082_bib24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116082_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.391","article-title":"Inflammasome: structure, biological functions, and therapeutic targets","volume":"4","author":"Dai","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.isci.2026.116082_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13406","article-title":"Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis","volume":"329","author":"Pandey","year":"2025","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.isci.2026.116082_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042230","article-title":"Absent in Melanoma 2 (AIM2) Regulates the Stability of Regulatory T Cells","volume":"23","author":"Lozano-Ruiz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116082_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41586-021-03231-w","article-title":"AIM2 in regulatory T cells restrains autoimmune diseases","volume":"591","author":"Chou","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116082_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ccell.2024.05.013","article-title":"Interruption of the intratumor CD8(+) T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy","volume":"42","author":"Geels","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116082_bib30","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1073\/pnas.1822001116","article-title":"PD-1(+) regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer","volume":"116","author":"Kamada","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.116082_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116082_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adr4458","article-title":"Succinate-loaded tumor cell-derived microparticles reprogram tumor-associated macrophage metabolism","volume":"17","author":"Lu","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.116082_bib33","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200962","article-title":"AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma","volume":"218","author":"Fukuda","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2026.116082_bib34","article-title":"Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation","volume":"13","author":"Qin","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116082_bib35","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.it.2023.06.001","article-title":"Targeting the metabolism of tumor-infiltrating regulatory T cells","volume":"44","author":"Wang","year":"2023","journal-title":"Trends Immunol."},{"key":"10.1016\/j.isci.2026.116082_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12967-024-05104-y","article-title":"Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.116082_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154951","article-title":"EFLA 945 restricts AIM2 inflammasome activation by preventing DNA entry for psoriasis treatment","volume":"127","author":"Chung","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.isci.2026.116082_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113231","article-title":"TRIM11 attenuates Treg cell differentiation by p62-selective autophagic degradation of AIM2","volume":"42","author":"Yu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.116082_bib39","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/art.42420","article-title":"NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1\/Sterol Regulatory Element Binding Transcription Factor 1 Pathway","volume":"75","author":"Meng","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.isci.2026.116082_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109710","article-title":"Overexpressed CD44 is associated with B-cell activation via the HA-CD44-AIM2 pathway in lupus B cells","volume":"255","author":"Yi","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.isci.2026.116082_bib41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-immunol-082223-044122","article-title":"Molecular Mechanisms Governing CD8 T Cell Differentiation and Checkpoint Inhibitor Response in Cancer","volume":"43","author":"Rausch","year":"2025","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.116082_bib42","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1158\/2159-8290.CD-23-1263","article-title":"CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool","volume":"14","author":"Kaptein","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.116082_bib43","article-title":"Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8(+) T cell exhaustion and anti-PD-1 resistance","volume":"5","author":"Chen","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2026.116082_bib44","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.immuni.2022.02.005","article-title":"Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8(+) T cell responses","volume":"55","author":"Banta","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116082_bib45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","article-title":"Spatial profiling technologies illuminate the tumor microenvironment","volume":"41","author":"Elhanani","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116082_bib46","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1007\/s00262-023-03410-w","article-title":"Murine regulatory T cells utilize granzyme B to promote tumor metastasis","volume":"72","author":"Tibbs","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.isci.2026.116082_bib47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.116082_bib48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","article-title":"Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy","volume":"17","author":"Toledo","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.116082_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jare.2024.02.009","article-title":"Targeting lipid metabolism of macrophages: A new strategy for tumor therapy","volume":"68","author":"Shao","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.isci.2026.116082_bib50","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ccell.2024.05.012","article-title":"Hand in hand to successful immunotherapy: CD8(+) T cells and M1-like macrophages swap the baton","volume":"42","author":"Hussein","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116082_bib51","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ccell.2024.04.011","article-title":"Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy","volume":"42","author":"van Elsas","year":"2024","journal-title":"Cancer Cell"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226014574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226014574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:44:40Z","timestamp":1794347080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226014574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2589004226014574"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116082","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AIM2 in tregs restrains anti-PD-1 efficacy by reinforcing immune suppression in MC38 colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116082"}}